Signal #149985 · SEC 8-K

$ARCT SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ARCT filing catalyst

Why did $ARCT trigger an AI stock catalyst alert?

$ARCT triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -0.5/10). Headline: Arcturus Therapeutics Reports Q3 Net Loss of $7.4M, Cash at $184.8M. Key points: - Q3 net loss improved to $7.4M ($0.26/share) vs. $13.4M ($0.49/share) YoY, but 9-month loss widened to $58.2M. - Cash and equivalents dropped to $184.8M as of Sep 30, 2026, from $230.9M at year-end 2025. - ARCT-032 Phase 2 data readout guided for Q2 2027; ARCT-2601 Phase 2 top-line data anticipated in H2 2027.

How did $ARCT stock react after the SEC filing?

After the SEC 8-K for $ARCT, observed market reaction: T0 price $9.36. Past moves do not guarantee future results.

Where can I get real-time $ARCT SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ARCT via Telegram and the VIP Web Terminal from €10/month.

$ARCT

$ARCT – Arcturus Therapeutics Reports Q3 Net Loss of $7.4M, Cash at $184.8M

Arcturus Therapeutics Holdings Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ARCT

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-0.5 / 10)

Q3 net loss improved to $7.4M ($0.26/share) vs. $13.4M ($0.49/share) YoY, but 9-month loss widened to $58.2M.
Cash and equivalents dropped to $184.8M as of Sep 30, 2026, from $230.9M at year-end 2025.
ARCT-032 Phase 2 data readout guided for Q2 2027; ARCT-2601 Phase 2 top-line data anticipated in H2 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →